"Given the initial data presented last year as well as recent talk of tumours shrinking to such a degree that they are un-biopsiable (even after 9 months??), additional interim data could well be positive."
My comment to this quote from ousia's post is that this is of major significance and as such little emphasis was given to it in the lead up to the ipo. Should not presentations attempting to garner support pull out all stops in order to get over the line?
- Forums
- ASX - By Stock
- realistic expectations
TSN
the sustainable nutrition group ltd
Add to My Watchlist
0.00%
!
1.0¢

"Given the initial data presented last year as well as recent...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
TSN (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online